Precision Resource

Re:Build Manufacturing is a U.S.-based family of industrial businesses founded in 2020 to design, engineer, and manufacture complex products across the full production lifecycle - from initial concept and prototyping through to high-volume output. Operating across more than 14 facilities and one million square feet of advanced manufacturing capacity, the company brings together over 400 engineers and more than 1,200 technical experts. Its stated mission is to ensure that the next generation of important products are made in America. The company serves customers across five core industry verticals: aerospace and defense, medical, electrification, energy and environment, and robotics and automation. It works with both startups and established companies, offering end-to-end capabilities that span integrated design, engineering, scalable manufacturing, and rigorous quality management. To date, Re:Build has successfully launched more than 800 specialized products for its customers. Re:Build's model combines organic operational capability with strategic mergers and acquisitions to build out its portfolio of industrial businesses. This structure allows it to deploy enabling technologies and manufacturing expertise across a coordinated group of companies rather than a single entity. Operational superiority and adaptability to how individual customers work are positioned as central to how the business operates.

We're a global technology and consulting company with over 62,000 professionals working across 46 countries to make the world safer, more connected, and more sustainable. Our teams develop advanced solutions that integrate sensors, communications, and command systems to protect forces and citizens in critical scenarios. From managing air traffic for more than 25% of the world's airspace to delivering cutting-edge defence systems, we bring deep technical expertise and a commitment to innovation that makes a real difference in people's lives. What drives us is the belief that technology should serve a purpose. That's why we invest heavily in R&D - 8.7% of our revenue goes toward developing the next generation of solutions in aerospace, space, mobility, and digital transformation. Whether we're helping Transport for London modernize their ticketing systems, deploying surveillance radars across the United States, or building sovereign AI capabilities for national security, we approach every project with the same focus on reliability, innovation, and long-term impact. Our work spans continents and industries, but our goal remains the same: using technology to build a more secure and connected future.

AMTSOL delivers technology solutions for pharmaceutical and biotechnology manufacturers, specialising in the digitalization and automation of GMP-regulated manufacturing environments. The company's work spans the full stack of manufacturing systems - from Level 2 automation through to Level 5 cloud integration and data analytics - and covers the complete project lifecycle, from consultancy and implementation to validation and continuous improvement. Its core service areas include Manufacturing Execution Systems (MES), OT networking, automation, cloud integration, data analytics, and both Computerized System Validation (CSV) and Commissioning, Qualification, and Validation (CQV) services. AMTSOL operates as a vendor-independent, single-partner provider, taking full responsibility for consultancy, project support, and ongoing optimisation across each engagement. GMP compliance and data integrity are central to its delivery model. The company works with pharmaceutical and biotechnology organisations across Singapore, Europe, and the United States, with a focus on Pharma 4.0 adoption and digital transformation. Its stated operational priorities include helping regulated manufacturers increase speed to market and improve operating efficiency.

A2e Technologies is an electronic design services firm based in San Diego, serving defense prime contractors, space companies, and enterprise technology clients. With over 20 years of operation, the company designs and delivers production-ready electronic systems - covering hardware, firmware, and validation - built to withstand demanding environments. It is not a prototyping shop; the emphasis is on systems that ship. The firm's technical scope spans the full stack of electronic engineering, including high-speed digital board design, FPGA programming, embedded Linux kernel development, PCB layout, hardware architecture, and system-level validation. Engineers take end-to-end ownership across a project - from architecture through firmware to lab validation - rather than working in siloed disciplines. A2e has invested over $2 million in advanced engineering tools and lab infrastructure to support this work from its secure San Diego facility. The company's operating model is built around rapid prototype-to-production cycles with experienced engineers who have shipped real products. Its stated priorities are schedule confidence, technical depth, and long-term reliability. The culture reflects a preference for deep technical ownership and measurable outcomes over process-heavy, facetime-focused environments.

Invivoscribe is a global leader in precision oncology diagnostics, dedicated to improving lives with standardized molecular testing solutions. For over 30 years, the company has pioneered the international standardization of molecular and flow cytometry testing, expanding access to advanced cancer therapies worldwide. Invivoscribe develops and manufactures a comprehensive portfolio of molecular assays, reagents, controls, and bioinformatics tools under ISO 13485 design control, supporting more than 700 clinical laboratories in over 160 countries. The company's Streamlined CDx (companion diagnostic) model accelerates the development of novel therapeutics, enabling personalized approaches to patient care. Invivoscribe's products consistently surpass industry and regulatory standards, playing a crucial role in identifying, stratifying, and monitoring hematologic cancers. Through its subsidiary, the Laboratory for Personalized Molecular Medicine (LabPMM), Invivoscribe offers extensive clinical diagnostic and biopharma services, providing globally standardized flow cytometry and molecular testing services for pharmaceutical and healthcare organizations across the U.S., Europe, and Asia.

We're a global team of about 10,000 people united by a straightforward mission: helping the world sustainably move, improve, and enjoy water. From our start in 1966 as a small Minnesota operation, we've grown into a company that serves customers in more than 150 countries - but we've never lost sight of what matters. Water isn't just our business; it's life's most essential resource, and we take seriously our responsibility to make it more accessible, safer, and smarter for everyone who relies on it. What we actually do day-to-day spans a pretty wide range, but it all connects back to water. We design and build the equipment that keeps swimming pools clean and energy-efficient, the filtration systems that make water safe to drink, the pumps that move water where it needs to go, and the industrial solutions that help businesses use water more responsibly. Whether it's a homeowner trying to keep their pool crystal clear, a farmer needing reliable irrigation, or a municipal water system serving thousands of people, we're the ones behind the scenes making it work. We operate about 130 locations across 34 countries, which means we're local enough to understand specific water challenges but big enough to deliver solutions at scale.